Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer
{{output}}
Background: Prognostic data on Japanese patients receiving durvalumab after chemoradiotherapy (CRT) for locally advanced non-small cell lung cancer (LA-NSCLC) are insufficient. Whether pneumonitis has prognostic implications in p... ...
